Ketamine Treatment Plans for Chronic Conditions
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Ketamine.
- Who it may be relevant to
- Registry conditions: Chronic Pain, Depressive Disorder, Anxiety Disorders, Chronic Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions
Overview
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
Detailed description
Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearpy.
The study will identify other treatment modalities used in concurrence with Ketamine. Psychotherapy, music therapy, and acutherapy are some of the most popular. How do these adjunct therapies affect the outcomes of Ketamine treatments?
Secondarily, the study will focus on these significant issues to observe the impact of Ketamine treatments and suicidal ideation. Suicidal ideation is multifaceted and is one reason for prescribing off-label Ketamine. Chronic issues such as depression, pain, and anxiety have been identified as underlying causes and may be improvable with Ketamine.
Interventions
- Drug Ketamine
The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions
Primary outcome measures
- Ketamine route of use acceptability. [Time frame: through study completion, an average of 1 year]
- Mental Health PHQ9 [Time frame: through study completion, an average of 1 year]
- Mental Health GAD7 [Time frame: through study completion, an average of 1 year]
- Mental Health PCL5 [Time frame: through study completion, an average of 1 year]
Eligibility criteria
Inclusion criteria
Must have an identifiable chronic condition.
Exclusion criteria
Healthy population
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- RIVER Telehealth — Helena
Identifiers
NCT: NCT06038409 · RIVERFoundation 001